MRC1 and cancer: Notably, no major differences were observed between fibroblast and fibrocyte co-injection with A549, H226 and H1650 cancer cells, with the exception that only human fibrocyte injection consistently promoted the expansion of mouse fibrocytes and the induction of the M2-like macrophage marker CD206.